ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
93.84 EUR
-2.14 (-2.23%)
Last: Mar 6, 2026, 07:00 PM
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 6 out of 10 to ABL. ABL was compared to 63 industry peers in the Health Care Equipment & Supplies industry. ABL gets an excellent profitability rating and is at the same time showing great financial health properties. ABL is not valued too expensively and it also shows a decent growth rate. This makes ABL very considerable for quality investing!
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- In the past year ABL was profitable.
- In the past year ABL had a positive cash flow from operations.
- Each year in the past 5 years ABL has been profitable.
- Each year in the past 5 years ABL had a positive operating cash flow.
1.2 Ratios
- ABL has a Return On Assets of 16.60%. This is amongst the best in the industry. ABL outperforms 95.24% of its industry peers.
- The Return On Equity of ABL (27.43%) is better than 95.24% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 8.88%, ABL is in the better half of the industry, outperforming 76.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 8.88% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- ABL has a Profit Margin of 31.88%. This is amongst the best in the industry. ABL outperforms 100.00% of its industry peers.
- In the last couple of years the Profit Margin of ABL has grown nicely.
- With a decent Operating Margin value of 18.29%, ABL is doing good in the industry, outperforming 77.78% of the companies in the same industry.
- ABL's Operating Margin has improved in the last couple of years.
- ABL has a Gross Margin of 56.19%. This is comparable to the rest of the industry: ABL outperforms 50.79% of its industry peers.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
2. ABL.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ABL is destroying value.
- The number of shares outstanding for ABL has been increased compared to 1 year ago.
- Compared to 5 years ago, ABL has less shares outstanding
- ABL has a better debt/assets ratio than last year.
2.2 Solvency
- ABL has an Altman-Z score of 5.30. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- ABL has a Altman-Z score of 5.30. This is amongst the best in the industry. ABL outperforms 87.30% of its industry peers.
- ABL has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 1.87, ABL belongs to the best of the industry, outperforming 82.54% of the companies in the same industry.
- ABL has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
- ABL has a better Debt to Equity ratio (0.23) than 71.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.3 |
ROIC/WACC0.89
WACC10%
2.3 Liquidity
- A Current Ratio of 1.70 indicates that ABL should not have too much problems paying its short term obligations.
- ABL's Current ratio of 1.70 is in line compared to the rest of the industry. ABL outperforms 57.14% of its industry peers.
- ABL has a Quick Ratio of 1.24. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- The Quick ratio of ABL (1.24) is better than 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. ABL.DE Growth Analysis
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- Measured over the past 5 years, ABL shows a small growth in Earnings Per Share. The EPS has been growing by 7.13% on average per year.
- The Revenue has been growing slightly by 5.67% in the past year.
- ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- The Earnings Per Share is expected to grow by 10.38% on average over the next years. This is quite good.
- ABL is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.06% yearly.
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 21.18 indicates a rather expensive valuation of ABL.
- ABL's Price/Earnings ratio is a bit cheaper when compared to the industry. ABL is cheaper than 68.25% of the companies in the same industry.
- ABL is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 26.29, which is the current average of the S&P500 Index.
- With a Price/Forward Earnings ratio of 18.99, ABL is valued on the expensive side.
- ABL's Price/Forward Earnings is on the same level as the industry average.
- The average S&P500 Price/Forward Earnings ratio is at 24.57. ABL is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.18 | ||
| Fwd PE | 18.99 |
4.2 Price Multiples
- ABL's Enterprise Value to EBITDA is on the same level as the industry average.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABL indicates a somewhat cheap valuation: ABL is cheaper than 60.32% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.41 | ||
| EV/EBITDA | 17.83 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ABL does not grow enough to justify the current Price/Earnings ratio.
- ABL has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)1.84
PEG (5Y)2.97
EPS Next 2Y10.76%
EPS Next 3Y10.33%
5. ABL.DE Dividend Analysis
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.27%.
- ABL's Dividend Yield is a higher than the industry average which is at 1.06.
- Compared to an average S&P500 Dividend Yield of 1.82, ABL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.27% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years6
Div Non Decr Years6
5.3 Sustainability
- ABL pays out 28.93% of its income as dividend. This is a sustainable payout ratio.
- ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP28.93%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (3/6/2026, 7:00:00 PM)
93.84
-2.14 (-2.23%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap163.06B
Revenue(TTM)44.33B
Net Income(TTM)13.98B
Analysts80
Price Target114.26 (21.76%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.27% |
Yearly Dividend2.05
Dividend Growth(5Y)10.37%
DP28.93%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)-8.74%
PT rev (3m)-9.01%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-0.04%
EPS NY rev (1m)0.14%
EPS NY rev (3m)0.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.03%
Revenue NY rev (1m)-0.18%
Revenue NY rev (3m)-0.64%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.18 | ||
| Fwd PE | 18.99 | ||
| P/S | 4.32 | ||
| P/FCF | 27.41 | ||
| P/OCF | 20.79 | ||
| P/B | 3.72 | ||
| P/tB | 8.86 | ||
| EV/EBITDA | 17.83 |
EPS(TTM)4.43
EY4.72%
EPS(NY)4.94
Fwd EY5.27%
FCF(TTM)3.42
FCFY3.65%
OCF(TTM)4.51
OCFY4.81%
SpS21.7
BVpS25.22
TBVpS10.59
PEG (NY)1.84
PEG (5Y)2.97
Graham Number50.14
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 8.88% | ||
| ROICexc | 9.99% | ||
| ROICexgc | 19.14% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.87%
OM growth 5Y4.37%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.26%
GM growth 5Y-0.01%
F-Score8
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.3 |
F-Score8
WACC10%
ROIC/WACC0.89
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.5%
EPS Next 2Y10.76%
EPS Next 3Y10.33%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year7%
Revenue Next 2Y7.19%
Revenue Next 3Y7.11%
Revenue Next 5Y7.06%
EBIT growth 1Y15.18%
EBIT growth 3Y-0.36%
EBIT growth 5Y9.67%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y6.65%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.48%
OCF growth 3YN/A
OCF growth 5YN/A
ABBOTT LABORATORIES / ABL.DE FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
What is the profitability of ABL stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for ABL stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABL.DE) is 21.18 and the Price/Book (PB) ratio is 3.72.
How sustainable is the dividend of ABBOTT LABORATORIES (ABL.DE) stock?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 28.93%.